Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorAkış, Merve
dc.contributor.authorKant, Melis
dc.contributor.authorIşık, İshak
dc.contributor.authorKısa, Pelin Teke
dc.contributor.authorKöse, Engin
dc.contributor.authorArslan, Nur
dc.contributor.authorIslekel, Hüray
dc.date.accessioned2021-03-19T07:40:27Z
dc.date.available2021-03-19T07:40:27Z
dc.date.issued2020en_US
dc.identifier.issn0004-5632
dc.identifier.issn1758-1001
dc.identifier.urihttps://doi.org/10.1177/0004563220935140
dc.identifier.urihttps://hdl.handle.net/20.500.12462/11242
dc.descriptionAkış, Merve (Balikesir Author)en_US
dc.description.abstractBackground Vitamin B12 deficiency frequently appears in phenylketonuria patients having a diet poor in natural protein. The aims of this study were to evaluate vitamin B12 status in phenylketonuria patients by using combined indicator of vitamin B12 status (cB12) as well as methylmalonic acid and homocysteine, more specific and sensitive markers, in comparison with healthy controls. Methods Fifty-three children and adolescents with phenylketonuria under dietary treatment and 30 healthy controls were assessed cross-sectionally. Serum vitamin B12 and folate concentrations were analysed by chemiluminescence immunoassay. Plasma methylmalonic acid and total homocysteine concentrations were measured by liquid chromatography-tandem mass spectrometry and liquid chromatography, respectively. cB12 was calculated by using a formula involving blood parameters. Results Methylmalonic acid and folate concentrations in phenylketonuria group were higher compared with controls. Methylmalonic acid concentrations were high in 56.5% of the patients and 26.7% of the controls with normal vitamin B12 concentrations. Based on cB12, a significant difference within the normal values was detected between the groups. However, although 24.5% of phenylketonuria patients and 13.3% of controls had decreased vitamin B12 status according to cB12, there was no significant difference. Conclusion Children and adolescents with phenylketonuria having a strict diet can be at risk of functional vitamin B12 deficiency. This deficiency can be accurately determined by measuring methylmalonic acid concentrations. Calculation of cB12 as a biochemical index did not provide additional information compared with the measurement of methylmalonic acid alone, but may be helpful for classification of some patients with increased methylmalonic acid as having adequate vitamin B12 status.en_US
dc.language.isoengen_US
dc.publisherSage Publicationsen_US
dc.relation.isversionof10.1177/0004563220935140en_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectPhenylketonuriaen_US
dc.subjectFunctional Vitamin B12 Deficiencyen_US
dc.subjectVitamin B12en_US
dc.subjectMethylmalonic Aciden_US
dc.subjectHomocysteineen_US
dc.subjectCombined Indicator of Vitamin B12 Statusen_US
dc.titleFunctional vitamin B12 deficiency in phenylketonuria patients and healthy controls: An evaluation with combined indicator of vitamin B12 status as a biochemical indexen_US
dc.typearticleen_US
dc.relation.journalAnnals of Clinical Biochemistryen_US
dc.contributor.departmentTıp Fakültesien_US
dc.contributor.authorID0000-0002-5338-7355en_US
dc.identifier.volume57en_US
dc.identifier.issue4en_US
dc.identifier.startpage291en_US
dc.identifier.endpage299en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster